Skip to main content

A Statistical Trial on Evaluation for Prognosis of Gastric Cancer

  • Conference paper
Gastric Cancer

Abstract

It is difficult to evaluate effectiveness of surgery and its adjuvant therapies on patients with curatively resected gastric cancer. Usually, survival time expressed in terms of months has been used as a scale to assess the performance of the therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Nakazato, H., Kato, K., Goto, M., Matsubara, Y. (1979). A Statistical Trial on Evaluation for Prognosis of Gastric Cancer. In: Herfarth, C.H., Schlag, P.M. (eds) Gastric Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67368-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67368-9_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67370-2

  • Online ISBN: 978-3-642-67368-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics